Recent Finacing
Recent Raise
PK MED develops injectable smart implants that combine drug-based agents and biodegradable scaffolds, with a lead PKM‑02 cell-homing implant to enhance donor hematopoietic stem cell engraftment and gout/regeneration programs.
